Medical and psychosocial factors and unfavourable low-density lipoprotein cholesterol control in coronary patients (Q38961970)

8 September 2017

Medical and psychosocial factors and unfavourable low-density lipoprotein cholesterol control in coronary patients (English)

1 reference

8 September 2017

7

Lars Gullestad

1 reference

8 September 2017

9

Toril Dammen

1 reference

8 September 2017

1

John Munkhaugen

1 reference

8 September 2017

8

Torbjørn Moum

1 reference

8 September 2017

4

Kari Peersen

1 reference

8 September 2017

2

Elise Sverre

1 reference

8 September 2017

10

Einar Husebye

1 reference

8 September 2017

5

Erik Gjertsen

1 reference

8 September 2017

3

Jan E Otterstad

1 reference

8 September 2017

6

Joep Perk

1 reference

8 September 2017

1 January 2017

1 reference

European Journal of Preventive Cardiology

8 September 2017

9

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

8 September 2017

24

1 reference

8 September 2017

981-989

1 reference

8 September 2017

9

1 reference

Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study

8 September 2017

1 reference

https://api.crossref.org/works/10.1177%2F2047487317693134

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047487317693134

Achievement of dual low-density lipoprotein cholesterol and high-sensitivity C-reactive protein targets more frequent with the addition of ezetimibe to simvastatin and associated with better outcomes in IMPROVE-IT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047487317693134

2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047487317693134

2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by repres

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047487317693134

Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047487317693134

Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047487317693134

Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047487317693134

EUROASPIRE IV: A European Society of Cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from 24 European countries.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047487317693134

Non-adherence to cardiovascular medications

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047487317693134

Provision, uptake and cost of cardiac rehabilitation programmes: improving services to under-represented groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047487317693134

Lipid lowering drug therapy in patients with coronary heart disease from 24 European countries--Findings from the EUROASPIRE IV survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047487317693134

Determinants for achieving the LDL-C target of lipid control for secondary prevention of cardiovascular events in Taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047487317693134

The role of medical and psychosocial factors for unfavourable coronary risk factor control

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047487317693134

Psychosocial aspects in cardiac rehabilitation: From theory to practice. A position paper from the Cardiac Rehabilitation Section of the European Association of Cardiovascular Prevention and Rehabilitation of the European Society of Cardiology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047487317693134

Impact of traditional and novel risk factors on the relationship between socioeconomic status and incident cardiovascular events.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047487317693134

Secondary prevention after acute myocardial infarction: drug adherence, treatment goals, and predictors of health lifestyle habits. The BLITZ-4 Registry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047487317693134

Clinical utility of inflammatory markers and advanced lipoprotein testing: advice from an expert panel of lipid specialists.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047487317693134

Adherence to cardiovascular therapy: a meta-analysis of prevalence and clinical consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047487317693134

Impact of medication therapy discontinuation on mortality after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047487317693134

Adherence with statin therapy in elderly patients with and without acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047487317693134

Interventions to improve adherence to lipid lowering medication

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047487317693134

Statin-associated muscle symptoms: impact on statin therapy-European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047487317693134

Fish consumption and CHD mortality: an updated meta-analysis of seventeen cohort studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047487317693134

21 January 2018

Identifiers

DOI

10.1177/2047487317693134

1 reference

8 September 2017

1 reference

PubMed ID

28196429